BioPlus Acquisition Corp.
BIOSDelisted Oct 6, 2023- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001856653
BioPlus Acquisition Corp. was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $135.2M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding BioPlus Acquisition Corp. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 32 | 30 | −2 |
| Shares | 12.4M | 12.5M | +70.6K (+0.6%) |
| Value | $132.1M | $135.2M | +$3.07M (+2.3%) |
New holders (4)
Institutions that held BioPlus Acquisition Corp. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 679,393 | $7.36M | 0.52% |
| BCK Capital Management LP | 74,268 | $805.1K | 0.41% |
| Virtu Financial LLC | 20,445 | $221.0K | 0.02% |
| Clear Street LLC | 1 | $11 | 0.00% |
Sold out (6)
Institutions that held BioPlus Acquisition Corp. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Quarry LP | 455,000 | $4.85M |
| Spartan Fund Management Inc. | 160,316 | $1.71M |
| Prelude Capital Management, LLC | 150,000 | $1.60M |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 100,000 | $1.06M |
| Bank of Montreal | 68,435 | $752.8K |
| UBS Group AG | 1,828 | $19.5K |